E-LIB Suche - Ergebnisse für: Wasserman, Scott

1

What Gets Measured, Gets Done: Understanding and Addressing..:

Ely, Todd L. ; Propheter, Geoffrey ; Jones, Rich.
Public Administration Review. 79 (2019) 5 - p. 768-771 , 2019

Link: https://doi.org/10.1111/..

2

Final Report of the OSLER-1 Study: Long-Term Evolocumab for..:

Koren, Michael ; Sabatine, Marc ; Giugliano, Robert...
Journal of Clinical Lipidology. 13 (2019) 3 - p. e53-e54 , 2019

Link: https://doi.org/10.1016/..

3

Evaluation of Nano-Composite XLPE Compound on Accelerated A..:

, In: 2019 IEEE Electrical Insulation Conference (EIC),

Han, Suh Joon ; Wasserman, Scott - p. 230-233 , 2019

Link: https://doi.org/10.1109/..

4

Martin/Hopkins Estimation, Friedewald and Beta-Quantificati..:

Martin, Seth ; Giugliano, Robert ; Murphy, Sabina...
Journal of Clinical Lipidology. 12 (2018) 2 - p. 565-566 , 2018

Link: https://doi.org/10.1016/..

5

HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Dens..:

Kohli, Payal ; Ganz, Peter ; Ma, Yifei...
Journal of the American Heart Association. 5 (2016) 5 - p. , 2016

Link: https://doi.org/10.1161/..

6

SCLEROSTIN NEUTRALIZING ANTIBODY ENHANCES BONE HEALING DURI..:

McDonald, Michelle ; Peacock, Lauren ; Mikulec, Kathy...
Bone. 46 (2010) - p. S27 , 2010

Link: https://doi.org/10.1016/..

7

Efficacy of Azithromycin for Treating Babesia microti Infec..:

Weiss, Louis M. ; Wittner, Murray ; Wasserman, Scott...
The Journal of Infectious Diseases. 168 (1993) 5 - p. 1289-1292 , 1993

Link: https://www.jstor.org/st..

8

Erratum to "C-Reactive Protein Levels and Plaque Regression..:

Nelson, Adam J. ; Puri, Rishi ; Brennan, Danielle M....
American Journal of Preventive Cardiology. 6 (2021) - p. 100153 , 2021

Link: https://doi.org/10.1016/..

9

Flame-Retardant Aspects of XLPE:

, In: Crosslinkable Polyethylene; Materials Horizons: From Nature to Nanomaterials,

Cogen, Jeffrey M. ; Chaudhary, Bharat I. ; Ghosh-Dastidar, Abhijit.. - p. 211-245 , 2021

Link: https://doi.org/10.1007/..

10

C-reactive protein levels and plaque regression with evoloc..:

Nelson, Adam J. ; Puri, Rishi ; Brennan, Danielle M....
American Journal of Preventive Cardiology. 3 (2020) - p. 100091 , 2020

Link: https://doi.org/10.1016/..

11

Lipoprotein(a) Particle Production as a Determinant of Plas..:

Chan, Dick C. ; Watts, Gerald F. ; Coll, Blai...
Journal of the American Heart Association. 8 (2019) 7 - p. , 2019

Link: https://doi.org/10.1161/..

12

Influence of Renal Function on Evolocumab Exposure, Pharmac..:

Lee, Edward ; Gibbs, John P. ; Emery, Maurice G....
Clinical Pharmacology in Drug Development. 8 (2019) 3 - p. 281-289 , 2019

Link: https://doi.org/10.1002/..

13

Long-Term Efficacy and Safety of Evolocumab in Patients Wit..:

Koren, Michael J. ; Sabatine, Marc S. ; Giugliano, Robert P....
Journal of the American College of Cardiology. 74 (2019) 17 - p. 2132-2146 , 2019

Link: https://doi.org/10.1016/..

14

Population pharmacokinetics and exposure–response modeling ..:

Kuchimanchi, Mita ; Grover, Anita ; Emery, Maurice G....
Journal of Pharmacokinetics and Pharmacodynamics. 45 (2018) 3 - p. 505-522 , 2018

Link: https://doi.org/10.1007/..

15

Controlled study of the effect of proprotein convertase sub..:

Watts, Gerald F ; Chan, Dick C ; Somaratne, Ransi...
European Heart Journal. 39 (2018) 27 - p. 2577-2585 , 2018

Link: https://doi.org/10.1093/..